Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03992170
Title Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive (DART4MM)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Azienda Ospedaliera Universitaria Senese
Age Groups: senior | adult
Covered Countries ITA

No variant requirements are available.